Atlas Trials

Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia

Clinical trial NCT03130465 · UNKNOWN

Trial details

NCT number
NCT03130465
Sponsor
Otsuka Pharmaceutical Europe Ltd
Status
UNKNOWN
Study type
OBSERVATIONAL
Schizophrenia
Start date
2017-07-13
Primary completion
2020-01-31
Enrollment
636

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.